Miravas

Venous pathology affects about 20 million French people, half of whom claim to have varicose veins, and therefore represents a considerable human and economic stake for public health. The Health Insurance encourages the adoption of new mini-invasive techniques and the development of ambulatory surgery to reconcile the comfort of the patient and the control of health expenses.

In December 2017, Miravas launched the hybrid Vbox, a unique medical device combining two thermal techniques, steam and radiofrequency, for the treatment of ambulatory venous pathology.

With the Vbox hybrid device for ambulatory treatment of varicose veins, Miravas SAS meets the government's desire to reduce healthcare costs.